All terms in EFO
| Label | Id | Description |
|---|---|---|
| myelodysplastic/myeloproliferative disease | MONDO_0020077 | [Clonal myeloid disorders that possess both dysplastic and proliferative features but are not properly classified as either MYELODYSPLASTIC SYNDROMES or MYELOPROLIFERATIVE disorderS.] |
| X-10510-to-palmitoyl sphingomyelin ratio | EFO_0021398 | [Quantification of the ratio of X-10510 to palmitoyl sphingomyelin in a sample.] |
| chromosome-defective micronuclei | EFO_1001778 | [Defective nuclei produced during the TELOPHASE of MITOSIS or MEIOSIS by lagging CHROMOSOMES or chromosome fragments derived from spontaneous or experimentally induced chromosomal structural changes.] |
| Charcot-Marie-Tooth disease type 1C | MONDO_0010995 | [Any Charcot-Marie-Tooth disease type 1 in which the cause of the disease is a mutation in the LITAF gene.] |
| arachidonate 20:4n6-to-1-arachidonoylglycerophosphoinositol ratio | EFO_0021397 | [Quantification of the ratio of arachidonate 20:4n6 to 1-arachidonoylglycerophosphoinositol in a sample.] |
| X-11820-to-cholesterol ratio | EFO_0021392 | [Quantification of the ratio of X-11820 to cholesterol in a sample.] |
| Lotus japonicus | NCBITaxon_34305 | |
| Hypodipsia | HP_0025382 | [Reduced fluid intake (drinking) in a clinical situation where the plasma molarity or sodium concentration normally would induce greater fluid intake.] |
| aspartylphenylalanine-to-X-14450--phenylalanylleucine ratio | EFO_0021391 | [Quantification of the ratio of aspartylphenylalanine to X-14450--phenylalanylleucine in a sample.] |
| obsolete_congenital sucrase-isomaltase deficiency with minimal starch tolerance | Orphanet_306446 | |
| phakomatosis cesiomarmorata | MONDO_0019326 | |
| ADSGEGDFXAEGGGVR-to-ADpSGEGDFXAEGGGVR ratio | EFO_0021394 | [Quantification of the ratio of ADSGEGDFXAEGGGVR to ADpSGEGDFXAEGGGVR in a sample.] |
| phakomatosis cesioflammea | MONDO_0019325 | |
| X-11440-to-4-androsten-3beta,17beta-diol disulfate 2 ratio | EFO_0021393 | [Quantification of the ratio of X-11440 to 4-androsten-3beta,17beta-diol disulfate 2 in a sample.] |
| obsolete_17q11.2 microduplication syndrome | Orphanet_139474 | [17q11.2 microduplication syndrome is characterized by dysmorphic features and intellectual deficit.] |
| lysine-to-glutaroyl carnitine ratio | EFO_0021390 | [Quantification of the ratio of lysine to glutaroyl carnitine in a sample.] |
| atypical Werner syndrome | MONDO_0019321 | [A heterogeneous group of cases that are clinically diagnosed as Werner syndrome (WS) but do not carry WRN gene mutations. Similar to classical WS caused by WRN mutations, patients generally exhibit an aged appearance and common age-related disorders at earlier ages compared to the general population.] |
| Chylothorax | EFO_1001780 | [The presence of chyle in the thoracic cavity. (Dorland, 27th ed)] |
| desmoplastic infantile astrocytoma | MONDO_0022963 | [A WHO grade I large cystic tumor that occurs almost exclusively in infants, with a prominent desmoplastic stroma having a neuroepithelial population consisting mainly of neoplastic astrocytes. It involves the superficial cerebral cortex and leptomeninges, and often attaches to the dura. Although clinically it presents as large tumor, it generally has a good prognosis following surgical resection. (Adapted from WHO)] |
| obsolete colchicine resistance | MONDO_0007348 |